Active ingredientNeostigmineCat. No. P-N035-001CAS 59-99-4Family · Pharmaceutical analytical standards
Neostigmine
A cholinesterase inhibitor synthesised in 1931 by Aeschlimann and Reinert, a simplified version of physostigmine: it is used for myasthenia gravis and to reverse the effect of muscle relaxants at the end of anaesthesia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?In 1934 Scottish physician Mary Walker found that physostigmine briefly relieved myasthenia gravis, 'the miracle at St Alfege's', named after her London hospital; in 1935 she showed the same benefit with neostigmine.
Go to the active ingredient →Active ingredientNeostigmineCat. No. P-N035-001CAS 59-99-4
Active ingredientNeostigmine BromideCat. No. P-N035-002CAS 114-80-7
Pharmacopoeial impurityNeostigmine EP Impurity ACat. No. P-N035-003CAS 3483-84-9
Pharmacopoeial impurityNeostigmine EP Impurity A BromideCat. No. P-N035-004CAS 1620-19-5
Pharmacopoeial impurityNeostigmine EP Impurity A IodideCat. No. P-N035-005CAS 2498-27-3
Pharmacopoeial impurityNeostigmine EP Impurity A MetilsulfateCat. No. P-N035-006CAS 4312-54-3
Pharmacopoeial impurityNeostigmine EP Impurity BCat. No. P-N035-007CAS 99-07-0
Pharmacopoeial impurityNeostigmine EP Impurity CCat. No. P-N035-008CAS 16088-19-0
Isotopically labelledNeostigmine Bromide EP Impurity C-d6Cat. No. P-N035-009CAS 2470126-73-7
NitrosamineN-Nitroso Neostigmine Impurity 1Cat. No. P-N035-011CAS 23040-64-4
Impurity2-(methylamino)phenolCat. No. P-N035-012CAS 611-24-5
Impurity2-Dimethylamino-1,4-benzoquinoneCat. No. P-N035-013CAS 3958-86-9
Impurity2-DimethylaminophenolCat. No. P-N035-014CAS 3743-22-4
ImpurityNeostigmine Impurity 1Cat. No. P-N035-015CAS 4939-59-7
Impurity3-(Methylamino)phenolCat. No. P-N035-016CAS 14703-69-6
Impurity3-(Methylamino)phenyl dimethylcarbamateCat. No. P-N035-017CAS 76418-45-6
Impurity3-NitrosophenolCat. No. P-N035-018CAS 20031-38-3
Impurity4-(dimethylamino)phenolCat. No. P-N035-019CAS 619-60-3
ImpurityNeostigmine Impurity 2Cat. No. P-N035-020CAS 63468-95-1
ImpurityNeostigmine Impurity 3 MetilsulfateCat. No. P-N035-021CAS 64050-77-7
ImpurityNeostigmine Impurity 4 MetilsulfateCat. No. P-N035-022CAS 64051-18-9
ImpurityNeostigmine Impurity 5 MetilsulfateCat. No. P-N035-023CAS 39218-17-2
ImpurityNeostigmine Impurity Dimer 1Cat. No. P-N035-024
Active ingredientNeostigmine MetilsulfateCat. No. P-N035-025CAS 51-60-5No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceNeostigmine bromide CRSEDQM code N0500000Family NeostigmineImpurityNeostigmine impurity A CRSEDQM code Y0001639Family NeostigmineReference substanceNeostigmine metilsulfate CRSEDQM code N0550000Family NeostigmineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.